A quantitative atlas of histone modification signatures from human cancer cells

Keyphrases

• Cancer Cells 100%
• Post-translational Modification 100%
• Histone Modification 100%
• Histone Post-translational Modifications 100%
• Proteomics 66%
• Cancer Cell Lines 66%
• Enzyme Abundance 66%
• Activity Level 33%
• Proteomics Methods 33%
• Epigenetics 33%
• In Cancer 33%
• Enzyme Expression 33%
• Molecular Properties 33%
• Proteomic Analysis 33%
• Transcriptome 33%
• Genomic Technologies 33%
• Histone H3 33%
• Xenograft Model 33%
• Knockdown 33%
• Methyltransferase 33%
• Cancer Development 33%
• Cancer Types 33%
• Enhancer of Zeste Homolog 2 (EZH2) 33%
• Chromatin Modification 33%
• Transcriptional Activation 33%
• Histone H4 33%
• Epigenetic Regulation 33%
• Tumor Burden 33%
• Integral Component 33%
• Transcriptome Analysis 33%
• Genomic Characterization 33%
• Nuclear Function 33%
• Quantitative Profiling 33%
• Predictive Utility 33%
• Non-epigenetics 33%
• Histone Variants 33%
• Histone-modifying Enzymes 33%
• Genomic Expression Profile 33%
• Enhancer of Zeste 33%
• Proteomics Characterization 33%
• Line Focus 33%
• Breast Cell Lines 33%
• Cancer Biology 33%
• Modifying Enzymes 33%
• H3K27 Trimethylation 33%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Histone Modification 100%
• Proteomics 100%
• Posttranslational Modification 60%
• Genomics 60%
• Histone Post-Translational Modification 60%
• Methylation 20%
• Methyltransferase 20%
• Enzyme 20%
• Enhancer Region 20%
• Transcriptomics 20%
• Gene Expression Profiling 20%
• Protein Expression 20%
• Transactivation 20%
• Histone H3 20%
• Transcription Initiation 20%
• EZH2 20%
• Histone H4 20%
• Tumor Volume 20%
• Histone-Modifying Enzymes 20%
• Chromatin 20%
• Histone Variant 20%
• Epigenetic Regulation 20%